EDGAR Filing Documents for 0001104659-23-089769

Form POS AM - Post-Effective amendments for registration statement:

SEC Accession No. 0001104659-23-089769

Filing Date

2023-08-10

Accepted

2023-08-10 16:00:46

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	POS AM	tm2323336-1_posam.htm	POS AM	678275
2	EXHIBIT 3.1	tm2323336d2_ex3-1.htm	EX-3.1	110766
3	EXHIBIT 10.19	tm2323336d2_ex10-19.htm	EX-10.19	47418
4	EXHIBIT 10.20	tm2323336d2_ex10-20.htm	EX-10.20	18971
5	EXHIBIT 23.3	tm2323336d2_ex23-3.htm	EX-23.3	3367
6	GRAPHIC	tm2323336d2_ex10-19img001.jpg	GRAPHIC	4313
7	GRAPHIC	lg_addextherapeutics-4c.jpg	GRAPHIC	29429
8	GRAPHIC	tb_external-4clr.jpg	GRAPHIC	75551
9	GRAPHIC	tb_internal-4clr.jpg	GRAPHIC	66998
10	GRAPHIC	tb_material-4clr.jpg	GRAPHIC	185719
11	GRAPHIC	bc_developed-4clr.jpg	GRAPHIC	113118
12	GRAPHIC	bc_dipraglurant-4clr.jpg	GRAPHIC	77529
	Complete submission text file	0001104659-23-089769.txt		1621882

Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202

Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555

Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)